Annual EBIT:
$1.02B+$243.53M(+31.54%)Summary
- As of today, GMAB annual earnings before interest & taxes is $1.02 billion, with the most recent change of +$243.53 million (+31.54%) on December 31, 2024.
- During the last 3 years, GMAB annual EBIT has risen by +$535.93 million (+111.73%).
- GMAB annual EBIT is now at all-time high.
Performance
GMAB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$364.56M+$176.44M(+93.78%)Summary
- As of today, GMAB quarterly earnings before interest & taxes is $364.56 million, with the most recent change of +$176.44 million (+93.78%) on June 1, 2025.
- Over the past year, GMAB quarterly EBIT has increased by +$102.49 million (+39.11%).
- GMAB quarterly EBIT is now -45.10% below its all-time high of $664.04 million, reached on June 30, 2020.
Performance
GMAB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$1.18B+$102.49M(+9.53%)Summary
- As of today, GMAB TTM earnings before interest & taxes is $1.18 billion, with the most recent change of +$102.49 million (+9.53%) on June 1, 2025.
- Over the past year, GMAB TTM EBIT has increased by +$312.62 million (+36.12%).
- GMAB TTM EBIT is now at all-time high.
Performance
GMAB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GMAB EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +31.5% | +39.1% | +36.1% |
3Y3 Years | +111.7% | +104.4% | +126.0% |
5Y5 Years | +156.8% | -45.1% | +4.1% |
GMAB EBIT Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +111.7% | -0.2% | +506.5% | at high | +83.6% |
5Y | 5-Year | at high | +156.8% | -0.2% | +506.5% | at high | +150.4% |
All-Time | All-Time | at high | +818.7% | -45.1% | +673.0% | at high | +798.2% |
GMAB EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $364.56M(+93.8%) | $1.18B(+9.5%) |
Mar 2025 | - | $188.13M(-40.0%) | $1.08B(+7.1%) |
Dec 2024 | $1.02B(+31.5%) | $313.34M(+0.4%) | $1.00B(+7.8%) |
Sep 2024 | - | $312.01M(+19.1%) | $931.50M(+7.6%) |
Jun 2024 | - | $262.08M(+124.8%) | $865.43M(+5.8%) |
Mar 2024 | - | $116.60M(-51.6%) | $817.81M(+7.4%) |
Dec 2023 | $772.06M(-13.3%) | $240.81M(-2.1%) | $761.32M(-14.1%) |
Sep 2023 | - | $245.94M(+14.7%) | $885.96M(-1.7%) |
Jun 2023 | - | $214.46M(+256.8%) | $901.34M(+4.2%) |
Mar 2023 | - | $60.11M(-83.6%) | $865.27M(-2.0%) |
Dec 2022 | $890.71M(+85.7%) | $365.46M(+39.9%) | $882.66M(+37.6%) |
Sep 2022 | - | $261.31M(+46.5%) | $641.53M(+23.1%) |
Jun 2022 | - | $178.39M(+130.2%) | $521.28M(+10.8%) |
Mar 2022 | - | $77.50M(-37.7%) | $470.48M(-1.8%) |
Dec 2021 | $479.66M(-50.3%) | $124.33M(-11.9%) | $479.15M(-3.6%) |
Sep 2021 | - | $141.07M(+10.6%) | $496.89M(+1.3%) |
Jun 2021 | - | $127.59M(+48.1%) | $490.53M(-52.2%) |
Mar 2021 | - | $86.16M(-39.4%) | $1.03B(+8.0%) |
Dec 2020 | $965.40M(+144.1%) | $142.07M(+5.5%) | $951.28M(-15.9%) |
Sep 2020 | - | $134.70M(-79.7%) | $1.13B(+7.9%) |
Jun 2020 | - | $664.04M(+6243.0%) | $1.05B(+158.5%) |
Mar 2020 | - | $10.47M(-96.8%) | $405.82M(+3.7%) |
Dec 2019 | $395.46M(+81.0%) | $322.46M(+517.1%) | $391.41M(+118.4%) |
Sep 2019 | - | $52.25M(+153.1%) | $179.21M(+13.3%) |
Jun 2019 | - | $20.64M(+623.4%) | $158.18M(-0.6%) |
Mar 2019 | - | -$3.94M(-103.6%) | $159.13M(-26.5%) |
Dec 2018 | $218.48M(+5.4%) | $110.26M(+253.1%) | $216.56M(-0.5%) |
Sep 2018 | - | $31.23M(+44.6%) | $217.57M(+11.3%) |
Jun 2018 | - | $21.59M(-59.6%) | $195.54M(-22.8%) |
Mar 2018 | - | $53.48M(-51.9%) | $253.38M(+22.7%) |
Dec 2017 | $207.19M(+32.5%) | $111.27M(+1108.5%) | $206.50M(+4.4%) |
Sep 2017 | - | $9.21M(-88.4%) | $197.78M(-8.7%) |
Jun 2017 | - | $79.43M(+1102.7%) | $216.59M(+36.5%) |
Mar 2017 | - | $6.60M(-93.6%) | $158.69M(+2.7%) |
Dec 2016 | $156.43M(+89.9%) | $102.55M(+266.0%) | $154.50M(+44.4%) |
Sep 2016 | - | $28.02M(+30.2%) | $107.02M(+6.7%) |
Jun 2016 | - | $21.52M(+791.2%) | $100.25M(+18.5%) |
Mar 2016 | - | $2.41M(-95.6%) | $84.58M(+3.6%) |
Dec 2015 | $82.39M(+74.6%) | $55.07M(+159.1%) | $81.67M(+121.5%) |
Sep 2015 | - | $21.25M(+263.7%) | $36.88M(-8.7%) |
Jun 2015 | - | $5.84M(+1281.4%) | $40.39M(+40.6%) |
Mar 2015 | - | -$494.60K(-104.8%) | $28.72M(-38.8%) |
Dec 2014 | $47.19M(+282.8%) | $10.27M(-58.5%) | $46.91M(+1.2%) |
Sep 2014 | - | $24.77M(+525.1%) | $46.36M(+106.7%) |
Jun 2014 | - | -$5.83M(-132.9%) | $22.43M(-10.7%) |
Mar 2014 | - | $17.69M(+81.8%) | $25.13M(+99.8%) |
Dec 2013 | $12.33M(+161.2%) | $9.73M(+1058.2%) | $12.58M(+751.1%) |
Sep 2013 | - | $840.10K(+126.9%) | $1.48M(+137.2%) |
Jun 2013 | - | -$3.13M(-160.9%) | -$3.97M(+53.1%) |
Mar 2013 | - | $5.14M(+474.2%) | -$8.46M(+60.9%) |
Dec 2012 | -$20.13M | -$1.37M(+70.2%) | -$21.65M(+31.6%) |
Sep 2012 | - | -$4.61M(+39.5%) | -$31.68M(+16.6%) |
Jun 2012 | - | -$7.62M(+5.4%) | -$38.00M(+12.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | -$8.05M(+29.4%) | -$43.17M(+7.4%) |
Dec 2011 | -$46.45M(-1029.9%) | -$11.40M(-4.2%) | -$46.63M(+8.5%) |
Sep 2011 | - | -$10.93M(+14.5%) | -$50.98M(-380.0%) |
Jun 2011 | - | -$12.78M(-11.0%) | -$10.62M(+22.6%) |
Mar 2011 | - | -$11.51M(+26.9%) | -$13.72M(+52.9%) |
Dec 2010 | -$4.11M(+94.8%) | -$15.75M(-153.5%) | -$29.16M(-399.2%) |
Sep 2010 | - | $29.42M(+285.2%) | -$5.84M(+92.3%) |
Jun 2010 | - | -$15.89M(+41.0%) | -$75.87M(+27.4%) |
Mar 2010 | - | -$26.95M(-456.1%) | -$104.56M(-8.0%) |
Dec 2009 | -$78.48M(+44.5%) | $7.57M(+118.6%) | -$96.84M(+42.4%) |
Sep 2009 | - | -$40.61M(+8.9%) | -$168.03M(-24.7%) |
Jun 2009 | - | -$44.57M(-131.9%) | -$134.75M(+8.7%) |
Mar 2009 | - | -$19.22M(+69.8%) | -$147.64M(+12.5%) |
Dec 2008 | -$141.30M(-74.7%) | - | - |
Dec 2008 | - | -$63.63M(-768.9%) | -$168.73M(-29.6%) |
Sep 2008 | - | -$7.32M(+87.3%) | -$130.18M(+17.7%) |
Jun 2008 | - | -$57.46M(-42.5%) | -$158.20M(-53.4%) |
Mar 2008 | - | -$40.32M(-60.7%) | -$103.11M(-26.5%) |
Dec 2007 | -$80.88M(-1.0%) | - | - |
Dec 2007 | - | -$25.08M(+29.0%) | -$81.49M(+1.1%) |
Sep 2007 | - | -$35.34M(-1390.5%) | -$82.37M(-17.0%) |
Jun 2007 | - | -$2.37M(+87.3%) | -$70.38M(+16.1%) |
Mar 2007 | - | -$18.70M(+28.0%) | -$83.85M(-4.2%) |
Dec 2006 | -$80.10M(-12.5%) | - | - |
Dec 2006 | - | -$25.96M(-11.2%) | -$80.45M(-13.1%) |
Sep 2006 | - | -$23.34M(-47.4%) | -$71.16M(-10.6%) |
Jun 2006 | - | -$15.84M(-3.5%) | -$64.37M(+4.7%) |
Mar 2006 | - | -$15.31M(+8.2%) | -$67.52M(+5.2%) |
Dec 2005 | -$71.17M(+5.6%) | - | - |
Dec 2005 | - | -$16.67M(-0.7%) | -$71.22M(+8.5%) |
Sep 2005 | - | -$16.55M(+12.9%) | -$77.82M(+1.2%) |
Jun 2005 | - | -$18.99M(+0.1%) | -$78.78M(-1.0%) |
Mar 2005 | - | -$19.00M(+18.3%) | -$78.03M(-3.2%) |
Dec 2004 | -$75.38M(-43.5%) | - | - |
Dec 2004 | - | -$23.27M(-32.9%) | -$75.60M(-3.7%) |
Sep 2004 | - | -$17.51M(+4.0%) | -$72.89M(-1.9%) |
Jun 2004 | - | -$18.24M(-10.1%) | -$71.51M(-28.6%) |
Mar 2004 | - | -$16.57M(+19.4%) | -$55.59M(-5.4%) |
Dec 2003 | -$52.55M(+15.0%) | - | - |
Dec 2003 | - | -$20.57M(-27.5%) | -$52.75M(+4.3%) |
Sep 2003 | - | -$16.13M(-594.1%) | -$55.11M(-2.6%) |
Jun 2003 | - | -$2.32M(+83.1%) | -$53.70M(+15.6%) |
Mar 2003 | - | -$13.73M(+40.1%) | -$63.65M(-2.1%) |
Dec 2002 | -$61.80M(-107.9%) | - | - |
Dec 2002 | - | -$22.93M(-55.8%) | -$62.34M(-24.1%) |
Sep 2002 | - | -$14.72M(-20.0%) | -$50.23M(-15.2%) |
Jun 2002 | - | -$12.27M(+1.2%) | -$43.59M(-15.5%) |
Mar 2002 | - | -$12.42M(-14.8%) | -$37.74M(-27.4%) |
Dec 2001 | -$29.73M(-209.8%) | -$10.82M(-33.7%) | -$29.62M(-57.5%) |
Sep 2001 | - | -$8.09M(-26.2%) | -$18.80M(-75.5%) |
Jun 2001 | - | -$6.41M(-49.1%) | -$10.71M(-149.1%) |
Mar 2001 | - | -$4.30M | -$4.30M |
Dec 2000 | -$9.60M(-255.2%) | - | - |
Dec 1999 | -$2.70M | - | - |
FAQ
- What is Genmab A/S annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Genmab A/S?
- What is Genmab A/S annual EBIT year-on-year change?
- What is Genmab A/S quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Genmab A/S?
- What is Genmab A/S quarterly EBIT year-on-year change?
- What is Genmab A/S TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Genmab A/S?
- What is Genmab A/S TTM EBIT year-on-year change?
What is Genmab A/S annual earnings before interest & taxes?
The current annual EBIT of GMAB is $1.02B
What is the all-time high annual EBIT for Genmab A/S?
Genmab A/S all-time high annual earnings before interest & taxes is $1.02B
What is Genmab A/S annual EBIT year-on-year change?
Over the past year, GMAB annual earnings before interest & taxes has changed by +$243.53M (+31.54%)
What is Genmab A/S quarterly earnings before interest & taxes?
The current quarterly EBIT of GMAB is $364.56M
What is the all-time high quarterly EBIT for Genmab A/S?
Genmab A/S all-time high quarterly earnings before interest & taxes is $664.04M
What is Genmab A/S quarterly EBIT year-on-year change?
Over the past year, GMAB quarterly earnings before interest & taxes has changed by +$102.49M (+39.11%)
What is Genmab A/S TTM earnings before interest & taxes?
The current TTM EBIT of GMAB is $1.18B
What is the all-time high TTM EBIT for Genmab A/S?
Genmab A/S all-time high TTM earnings before interest & taxes is $1.18B
What is Genmab A/S TTM EBIT year-on-year change?
Over the past year, GMAB TTM earnings before interest & taxes has changed by +$312.62M (+36.12%)